SS-31 is a mitochondria-targeted antioxidant peptide
prescribed to support cellular energy production and
longevity. Administered subcutaneously, it is designed for
use in structured protocols and should not be stacked with
MOTS-C.
Key Benefits:
– Mitochondria-targeted antioxidant
– Supports cellular energy production
– Structured dosing: 5–10 units daily, max 12 weeks
– Do not stack with MOTS-C
All therapies are prescribed following individual medical
assessment and administered under direct clinical supervision
in full accordance with DHA regulations.